Filter
204
Filtered Results: 204
Text search:
monoclonal
antibodies
Featured
Recommendations
33
New Publications
36
Language
Document type
No document type
82
Guidelines
56
Studies & Reports
25
Manuals
15
Fact sheets
11
Strategic & Response Plan
7
Resource Platforms
3
Training Material
2
Infographics
2
Situation Updates
1
Countries / Regions
India
15
Global
10
South Africa
6
Latin America and the Carribbean
5
Germany
5
Syria
3
Philippines
3
Venezuela
3
Congo, Democratic Republic of
3
Nigeria
2
Niger
2
Afghanistan
2
Africa
2
West and Central Africa
2
Middle East and North Africa
2
France
2
Spain
2
Russia
2
Mali
2
Indonesia
2
Pakistan
2
North Macedonia
1
Colombia
1
Mexico
1
Ukraine
1
El Salvador
1
Turkey
1
Benin
1
Sierra Leone
1
Rwanda
1
Kazakhstan
1
Chile
1
Cameroon
1
Senegal
1
Congo-Brazzaville
1
Burkina Faso
1
Peru
1
Morocco
1
Qatar
1
Mauritania
1
USA
1
Haiti
1
Dominican Republic
1
Tanzania
1
Jordan
1
Saudi Arabia
1
Western Pacific Region
1
Western and Central Europe
1
Tunisia
1
United Kingdom
1
Portugal
1
Belarus
1
Israel
1
East and Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Argentina
1
Lebanon
1
Vietnam
1
Uganda
1
Nicaragua
1
Brazil
1
Namibia
1
Egypt
1
Sudan
1
Yemen
1
Ethiopia
1
Honduras
1
Chad
1
Libya
1
Iraq
1
Somalia
1
Liberia
1
Ecuador
1
Madagascar
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Guidelines
24
COVID-19
17
Vaccine-preventable Diseases
8
Drugs & Medical Equipment
6
Disease Prevention & Control
6
Virology
5
Non-communicable Diseases
5
Rabies
4
Pediatrics
3
Policies & Guidelines HIV & TB
3
NTDs & Others
3
Paediatrics
2
General Guidelines
2
Cancer Treatment & Resources
2
NCD
2
Hemorrhagic Fever
2
Diarrhoeal Disease/Cholera
2
Women & Child Health
2
Studies & Reports
2
Respiratory Infections
2
Immunization
2
Parasitology
2
Malaria
2
TB
2
Communicable Diseases
1
Clinical Training
1
Hepatitis
1
Public Health
1
Disaster Preparedness
1
Bacteriology
1
Cancer
1
Vector Control
1
Palliative Care
1
Infection Control & Prevention (IPC)
1
Yersinia pestis (Plague)
1
Countries
1
Yellow Fever
1
Policies
1
Information, Education and Communication (IEC)
1
Capacity Building
1
Humanitarian Crisis
1
Statistics
1
COPD/Asthma
1
Gynaecology & Obstetrics
1
Leishmaniasis
1
Laboratory Technologies
1
HIV & STI
1
Age & Elderly
1
Toolboxes
Clinical Guidelines
17
SARS-CoV-2 Variants
9
Inactivated COVID-19 Vaccines
7
Laboratory
6
Surveillance & Contact tracing
6
Genomic sequencing
6
Testing Guidelines
6
Surveillance
5
Public Health
5
Treatment Guidelines
5
Essential Medicines & Devices Lists
5
Laboratory Guidance
4
Immunization Guidelines
4
Vaxzevria (Astra Zeneca)
4
Outbreak Prevention & Control
3
Clinical Aspects, Treatment & Prevention
3
Influenza Prevention & Control
3
Research
3
Prevention & Preparedness
3
Clinical Aspects
3
Diagnostics & Laboratory Guidance
3
Country specific documents
3
Scientific & Research Studies
3
Covaxin
3
Clinical Aspects & Diagnostics
3
Disease Prevention & Control
3
Preparedness & Prevention
3
Ebola Prevention & Control
2
Influenza
2
Vaccination
2
Essential List
2
Training, others
2
Appeals and Response Plans
2
Global Impact: Socio-economic, health services, TB & HIV
2
Essential Medicines & Medical Devices
2
Fair Allocation & Ethical Aspects
2
COVAX Initiative
2
Moderna
2
Biontech/Pfizer Comirnaty
2
Infectious Diseases
2
MPOX - Monkeypox
2
Health Financing Toolbox
2
Alzheimer's Disease & Dementia
2
Antiretroviral Treatment ART
2
Meningitis & Encephalitis
2
Drugs
1
Assessment & Studies
1
ART Drug Resistance
1
Treatment & Prevention
1
Vaccines & Immunization
1
Yellow Fever
1
Clinical Guidelines
1
Country specific
1
Key Resources
1
Children & Adolescents
1
Plague
1
Drug resistance
1
Cholera Prevention & Control
1
Latin America
1
Ebola & Marburg
1
Ebola
1
Public Health
1
International
1
Climate & Health
1
Context & Facts
1
Situation Reports & Updates
1
Research & Development
1
Studies
1
Public Health
1
Risk Communication & Community Engagement
1
For General Public & Community
1
For Health Worker
1
Oxygen Therapy
1
Situation Reports COVID-19
1
Access & Strategy
1
Vaccine Candidates & Research
1
Non-pharmaceutical interventions (NPIs)
1
Presentation
1
Long COVID/ Post-COVID Syndrome
1
Vector-based Vacines General
1
Johnson & Johnson
1
Research & Pipeline
1
Essential Medicines
1
Quality Assurance
1
General documents One Health
1
Guidelines & Manuals
1
Zoonoses
1
Health Impact & Climate Change
1
Strategies & Roadmaps
1
Clinical Aspects & Diagnostics
1
Clinical Aspects & Diagnostics
1
Studies & Reports
1
Studies & Reports
1
Studies & Reports
1
Taeniasis/Cysticercosis
1
Access to treatment and laboratory
1
General Information & Methodology
1
Clinical Aspects & Diagnosis
1
Prevention & Strategies
1
Studies & Reports
1
Statistics & Facts
1
Prevention & Strategies
1
Clinical Guidelines
1
Neurological Disorders
1
Zika
1
Diarrhoea
1
Clinical Guidelines
1
Chikungunya Prevention & Control
1
Clinical Guidelines
1
Laboratory
1
Context & Facts
1
Marburg Virus Situation Reports
1
Chikungunya
1
Laboratory & Diagnostics
1
Action Plans, Policies & Response
1
AMR
1
Public Health
1
Plague Prevention & Control
1
PQDx 0197-045-00 WHO
PQDx PR
March /2016, version 2.0
This document updates recommendations for HIV testing by laboratories in the United States and offers approaches for reporting test results to persons ordering HIV tests and to public health authorities. The recommended algorithm is a sequence of tests used in combination to improve the accuracy of ...
Enfrentando la enfermedad de Alzheimer en los países en desarrollo.
Rev Neuropsiquiatr 80 (2), 2017 (P. 105-110)
Recibido: 03/02/2017 Aceptado: 12/06/2017
Product:BDFACSCountTM InstrumentSystemwithFACSCountTM ControlKitandBD FACSCountTM CD4ReagentKit(AbsoluteandPercentageCD4+Counts)
Number: PQDx 0133-045-00
0133-045-00 WHO
PQDx PR
June/2016, version 2.0
This module is part of the WHO series The Immunological Basis for Immunization, which was initially developed in 1993 as a set of eight modules, comprising one module on general immunology and seven modules each devoted to one of the vaccines recommended for the Expanded Programme on Immunization, i...
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc...
February 2021.
Improving our response to the ongoing COVID-19 pandemic in Africa requires regularly updated information, constant innovation, and considerable support towards research and development (R&D) for priorities that respond to the African realities. Shaping the research agenda and stimula...
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th...
A living WHO guideline on drugs for covid-19
recommended
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3379
Rapid Recommendation and visual graph. This is the fifth version (update 4) of the living guideline (BMJ 2020;370:m3379). When citing this article, please consider adding the update number and date of access for clarity. The publication of the RE...
This document aims to describe a minimum set of surveillance activities recommended at the national level to detect and monitor the relative prevalence of SARS-CoV-2 variants and outline a set of activities for the characterization and assessment of risk posed by these variants. A set of indicators ...
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been ...
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian...
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th...
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in development worldwide. It evaluates to what extent...
